ALLOISIO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 3.413
EU - Europa 842
AS - Asia 205
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
SA - Sud America 3
Totale 4.606
Nazione #
US - Stati Uniti d'America 3.340
FI - Finlandia 243
IE - Irlanda 161
NG - Nigeria 129
CN - Cina 123
DE - Germania 83
FR - Francia 80
IT - Italia 70
CA - Canada 67
SE - Svezia 63
NL - Olanda 41
GB - Regno Unito 38
IL - Israele 29
TR - Turchia 26
RU - Federazione Russa 22
BE - Belgio 19
IN - India 11
IR - Iran 11
UA - Ucraina 6
EG - Egitto 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
GR - Grecia 4
PA - Panama 4
AU - Australia 3
RO - Romania 3
BR - Brasile 2
EU - Europa 2
ID - Indonesia 2
TT - Trinidad e Tobago 2
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
HK - Hong Kong 1
NO - Norvegia 1
PL - Polonia 1
SI - Slovenia 1
TW - Taiwan 1
Totale 4.606
Città #
Wilmington 834
Chandler 502
San Mateo 283
Helsinki 243
Ann Arbor 235
Leawood 166
Dublin 161
Lawrence 139
Princeton 139
Benin City 129
Shanghai 121
Boardman 102
Fairfield 92
Woodbridge 86
Paris 78
New York 65
Toronto 59
Ashburn 57
Amsterdam 40
London 26
Kocaeli 25
Milan 23
Moscow 21
Brussels 18
Seattle 18
Monmouth Junction 16
Norwalk 13
San Diego 13
Phoenix 11
Ardabil 9
Abbiategrasso 8
Los Angeles 8
Redwood City 7
Falkenstein 6
Frankfurt am Main 6
Pune 6
Des Moines 5
Redmond 5
Andover 4
Augusta 4
Sacramento 4
Winnipeg 4
Athens 3
Barnsley 3
Cambridge 3
Clearwater 3
Doncaster 3
Henderson 3
Houston 3
Jacksonville 3
Santa Clara 3
Evanston 2
Falls Church 2
Geneva 2
Jakarta 2
Las Vegas 2
Ottawa 2
São Paulo 2
Tappahannock 2
Tunapuna 2
Washington 2
Alexandria 1
Chicago 1
Ferrara 1
Genoa 1
Gurnee 1
Hanover 1
Heimberg 1
Hyderabad 1
Jerusalem 1
Krimpen Aan Den Ijssel 1
La Canada Flintridge 1
Ljubljana 1
Mainz 1
Manchester 1
Melbourne 1
Mersin 1
Montichiari 1
Montreal 1
Montréal 1
Mumbai 1
Nanjing 1
Nuremberg 1
Raleigh 1
Rome 1
Roubaix 1
Sheffield 1
Sjomarken 1
Taipei 1
Tallinn 1
Vancouver 1
York 1
Zurich 1
Totale 3.870
Nome #
Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study 70
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center 69
K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers 65
Biological characteristics and long-term outcomes in node-negative breast cancer 63
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer 60
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 55
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial 54
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 52
Lung resection for metastatic sarcomas: total survival from primary treatment. 51
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 51
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 51
Targeted therapy for thymic epithelial tumors: a new horizon ? Review of the literature and two cases reports 50
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival 50
Gene methylation in pleural mesothelioma : Correlations with clinico-pathological features and patient’s follow-up 49
Analysis of the learning curve of the surgical procedure for the treatment of thoracic disc herniation using anterolateral trans-thoracic approach with the aid of Image-Guided System (IGS) 49
A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival 49
Case 2. Mediastinal liposarcoma in a patient with previous testicular cancer 49
Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status 48
Combined radiation and chemotherapy in esophageal cancer 48
Reproducibility of the WHO classification of thymomas: practical implications 47
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients 46
Lung resection as salvage treatment for metastatic osteosarcoma. 46
Analysis Indicates Low Incremental Cost-Effectiveness Ratio for Implementation of Lung Cancer Screening in Italy 45
Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: a case-report 44
Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: results of a dose-intensity study 43
Short schedule of cisplatin and vinorelbine: A dose-finding study in non-small-cell lung cancer 43
AGE AND PULMONARY RESECTION FOR LUNG-CANCER 43
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: Clinical and molecular results from a prospective study 42
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 41
Robotic Surgery, VATS, and Open Surgery for Early Stage Lung Cancer: Comparison of Costs and Outcomes at a Single Institute 41
Role of pathologic response after primary chemoradio-therapy and esophagectomy for predicted T3-4 N0-1 Mo Squamous carcinoma of the thoracic esophagus 40
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 40
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 40
Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: Result of a dose-intensity study 40
Analysis of the learning curve of the surgical procedure for the treatment of thoracic disc herniation using anterolateral transthoracic approach with the aid of image-guided system 40
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery 39
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? 39
OMEGA, A Randomized Trial of Local Ablative Therapy Vs. Conventional Treatment in Oligometastatic NSCLC - Trial in Progress 39
Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma 39
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer 39
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP) 38
Percutaneous Vertebral Augmentation in Metastatic Disease: State of the Art 38
Dante: A randomised trial on early diagnosis of lung cancer with low-dose spiral CT (LDCT); Initial announcement 38
SURGICAL PROGNOSIS IN STAGE-I BRONCHOGENIC-CARCINOMA OF THE MIDDLE LOBE 38
“La localizzazione anatomica delle micrometastasi di carcinoma mammario al linfonodo sentinella e’ predittiva dello stato della dissezione ascellare” 38
Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients 37
MULTIMODAL APPROACH TO THE MANAGEMENT OF METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC) DUE TO SOLID TUMORS 37
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients 37
Adjuvant chemotherapy following pneumonectomy for non small cell lung cancer: a multivariate survival analysis on a multicentric series of 61 patients 37
Protection of right pneumonectomy bronchial sutures with a pedicled thymus flap 37
A Very Elderly Lung Cancer Patient: Case Report of a Long Disease Free Survival 37
Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease 37
Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients. 37
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients 36
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer 36
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications 36
A video-assisted thoracoscopic technique to encircle the four pulmonary veins: A new surgical intervention for atrial fibrillation ablation 36
Molecular and cytologic analysis of sputum specimens in patients with lung cancer 36
Molecular and cytologic analysis of sputum specimens in patients with lung cancer 36
Surgical Procedures in the DANTE Trial, A Randomized Study of Lung Cancer Early Detection with Spiral Computed Tomography Comparative Analysis in the Screening and Control Arm 35
Surgical sentinel lymph node biopsy in early breast cancer. Could it be avoided by performing a preoperative staging procedure? A pilot study 35
Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer 35
Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy and medical treatment in 60 patients 35
Malignant pleural mesothelioma (MPM) evaluation with C-11-methionine PET/CT before and after talc pleurodesis 35
Dante: A randomized study on lung cancer screening with low-dose spiral CT (LDCT): End of accrual and preliminary results 35
Non-small-cell lung cancer: Detection of mediastinal lymph node metastases by endoscopic ultrasound and CT 35
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. 34
Lung cancer screening with spiral CT Baseline results of the randomized DANTE trial 34
Larynx preservino strategy in patients with squamous cell carcinoma of the cervical esophagus 34
Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer 34
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations 33
Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue 33
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 32
Positron emission tomography with F18-fluorodeoxyglucose (FDG-PET) in malignant pleural mesothelioma (MPM): Evaluation of response to chemotherapy by quantitative assessment of standardized uptake value (SUV) 32
Survival Outcomes in Malignant Pleural Mesothelioma Patients Fit for Surgery According to Type of Procedure and Completeness of Resection 32
TRACHEAL DIVERTICULUM - A RARE CAUSE AND CONSEQUENCE OF CHRONIC COUGH - CASE-REPORT 32
Dante: A randomized study on lung cancer screening with spiral CT. Work in progress 32
Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy 31
Optimizing residual surgery for patients with primary extragonadal germ cell tumors 29
Bronchoalveolar lavage in suspected COVID-19 cases with a negative nasopharyngeal swab: a retrospective cross-sectional study in a high-impact Northern Italy area 29
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM) 28
Multilevel En Bloc Spondylectomy for Tumors of the Thoracic and Lumbar Spine Is Challenging But Rewarding 27
Surgical treatment of synchronous colorectal liver and lung metastases: the usefulness of thoracophrenolaparotomy for single stage resection 27
IRF4 Instructs Effector Treg Differentiation and Immune Suppression in Human Cancer 26
MICROMETASTASES SITE AND SIZE TO SENTINEL LYMPH NODES PREDICT ADDITIONAL AXILLARY METASTASES IN PATIENTS WITH BREAST CANCER 26
Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy 26
What counts more: the patient, the surgical technique, or the hospital? A multivariable analysis of factors affecting perioperative complications of pulmonary lobectomy by video-assisted thoracoscopic surgery from a large nationwide registry 26
Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer 25
Pathological features of nodal micrometastases. Predict distant failure in patients affected by breast cancer. 25
Parametrical analyses at baseline and interim PET for response assessment and outcome definition in patients affected by malignant pleural mesothelioma (MPM) 25
Upfront high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (PBSCT) for international germ-cell cancer collaborative group (IGCCCG): Poor prognosis germ cell tumor (GCT) patients 25
Short-schedule cisplatin andvinorelbine as induction chemotherapy in stage IIIA(N2)-IIIB non small cell lung cancer (NSCLC) 25
Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC). 24
THE ROLE OF PENTRAXIN 3, AN ACUTE PHASE PROTEIN, AND OF SMOLDERING INFLAMMATION AT THE TUMOR SITE IN LUNG CANCER PROGRESSION AND PROGNOSIS. A CLINICOPATHOLOGIC STUDY 24
Consolidation high-dose chemotherapy for patients with primary mediastinal nonseminomatous germ cell tumor 24
Primary pulmonary meningioma: report of a case and review of the literature 23
Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients 23
Molecular alterations in spontaneous sputum of cancer-free heavy smokers : results from a large screening program 23
Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy 23
Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography 22
Totale 3.804
Categoria #
all - tutte 38.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 0 0 0 0 0 0 0 0 0 0 0 75
2020/20211.562 16 12 12 15 8 518 254 73 363 148 3 140
2021/2022753 60 9 10 149 6 3 35 113 56 105 172 35
2022/20231.587 320 64 155 156 111 135 7 95 267 174 89 14
2023/2024796 79 149 212 52 30 86 74 44 23 47 0 0
Totale 4.773